TP53 and breast cancer: Finally, for the 13 patients diagnosed with HER2-enriched BC, 30.8% (4/13) had a P/LP variant in BRCA2, TP53, FH and RECQL4 genes (7.7% each), these latter two genes with an still to be determined relevance in BC (Figure 2).